1-2 of 2
Roger D. Dansey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia

Clinical Trials & Observations
Susan M. O'Brien, Nicole Lamanna, Thomas J. Kipps, Ian Flinn, Andrew D. Zelenetz, Jan A. Burger, Michael Keating, Siddhartha Mitra, Leanne Holes, Albert S. Yu, David M. Johnson, Langdon L. Miller, Yeonhee Kim, Roger D. Dansey, Ronald L. Dubowy, Steven E. Coutre
Journal: Blood
Blood (2015) 126 (25): 2686–2694.
https://doi.org/10.1182/blood-2015-03-630947
Published: 2015
Includes: Supplemental data
Journal Articles

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)

Richard R. Furman, MD, Jeff P. Sharman, MD, Steven E. Coutre, MD, Bruce D. Cheson, MD, John M. Pagel, MD, PhD, Peter Hillmen, MBChB, PhD, Jacqueline C. Barrientos, MD, Andrew D. Zelenetz, MD, PhD, Thomas J. Kipps, MD, PhD, Ian Flinn, MD, PhD, Paolo Ghia, MD, PhD, Herbert Eradat, MD, Thomas Ervin, MD, Nicole Lamanna, MD, Michael Hallek, MD, Bertrand Coiffier, MD, PhD, Andrew R. Pettitt, PhD, FRCPath, Shuo Ma, MD, PhD, Stephan Stilgenbauer, MD, Paula Cramer, MD, Maria Aiello, Dave M. Johnson, Langdon L. Miller, MD, Daniel Li, PhD, Thomas M. Jahn, MD, PhD, Roger D. Dansey, MD, Susan M. O'Brien, MD
Journal: Blood
Blood (2013) 122 (21): LBA-6.
https://doi.org/10.1182/blood.V122.21.LBA-6.LBA-6
Published: 2013